• Press Release

Mount Sinai Scientist Recognized for Outstanding Basic Research Contributions to Neuropsychopharmacology

  • New York, NY
  • (December 09, 2019)

Scott Russo, PhD, Professor of Neuroscience and Director of the Center for Affective Neuroscience within the Nash Family Department of Neuroscience and The Friedman Brain Institute at Mount Sinai, has been awarded the 2019 Daniel H. Efron Research Award from the American College of Neuropsychopharmacology (ACNP). The award is given in recognition of outstanding basic research contributions to neuropsychopharmacology, the study of the neural mechanisms by which drugs affect behavior. Dr. Russo was presented the award at the 58th Annual Meeting of the ACNP in Orlando, Florida.

Dr. Russo is recognized internationally for his contributions to the understanding of neural and immunological mechanisms underlying neuropsychiatric disorders such as depression and anxiety. His translational studies of depression-like behaviors in rodent models have identified novel disease mechanisms in depressed humans. The Russo Lab at Mount Sinai uses a broad array of tools to gain insight into how the brain and body adapt to stress and how a failure in adaptation may result in pathological behaviors associated with depression and anxiety.

Over the past decade, Dr. Russo has made outstanding contributions to psychopharmacology and the molecular understanding of neuropsychiatric disease. He has received numerous honors and awards, which include the Johnson & Johnson/IMHRO Rising Star in Translational Research and being named a Kavil National Academy of Science Frontiers Fellow.

Dr. Russo is the latest in a long line of Mount Sinai winners of ACNP’s prestigious Efron Award, including:

  • Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System
  • Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System
  • Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs and Director of The Friedman Brain Institute
  • Joseph D. Buxbaum, PhD, Professor of Psychiatry, Genetics and Genomic Sciences, and Neuroscience, and Director of The Seaver Autism Center for Research and Treatment
  • Paul J. Kenny, PhD, Ward-Coleman Professor and Chair of the Nash Family Department of Neuroscience    

“This is testimony to the dominant role Mount Sinai has played in psychiatric neuroscience over a generation,” said Dr. Nestler. “Dr. Russo’s highly innovative and transformative research program is revealing fundamentally novel mechanisms of stress, depression, and resilience, and promises new treatments for several stress-related illnesses.” 

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.